Akrevia Therapeutics, Inc.

Akrevia Therapeutics, Inc.

Akrevia Therapeutics, Inc.

Akrevia Therapeutics is discovering and developing the next generation of cancer immunotherapies, offering the promise of safer, more efficacious therapeutics
Raised
$130.5M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$100,500,000
Venture capital (Series B) - 2020
Atlas Venture Bay City Capital RiverVest +7
$30,000,000
Venture capital (Series A) - 2018
Team Size
1–10
Employees
$100,500,000 Venture capital (Series B)
FinSMEs , Pulse 2.0

Xilio Therapeutics Raises $100.5M in Series B Financing

$30,000,000 Venture capital (Series A)
FinSMEs , PE HUB , MedCity News , +1

Akrevia Therapeutics Raises $30M in Series A Financing

Funding Health